56.8 F
New York
Monday, November 30, 2020

Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) Shares Get a Boost on Conditional Approval Notice

Must read

Will Agenus Inc. (AGEN) Find a Support Level Soon?

Agenus Inc. (AGEN) shares are trading at higher $3.71 and the avg recommendation for the stock is Strong Buy. To add more color to...

Niu Technologies (NIU)’s Stock is Jumping, Here is Why

Niu Technologies (NIU) shares are trading at higher $31.58 and the avg recommendation for the stock is Strong Buy, while the current analyst price...

The Forecast Just Changed on Amgen Inc. (NASDAQ:AMGN)

Amgen Inc. (AMGN) shares are trading at higher $224.81 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Is the Rough Ride Over for SPI Energy Co. Ltd. (SPI)

SPI Energy Co. Ltd. (SPI) shares are trading at higher $11.91. To add more color to this target, the company’s high over the last...

The sideways range continues to build out in shares of Emerald Health Therapeutics Inc (OTCMKTS:EMHTF). We have been looking for new catalysts to emerge here to help this stock challenge key resistance in the $4/share area. One such candidate is the company’s recent announcement that it has received conditional approval of the TSX Venture Exchange regarding its 51:49 joint venture with San Diego-based Emerald Health Bioceuticals, to be called Emerald Health Naturals.

According to the release, “The Company will invest $5,000,000 for 51% equity ownership of EHN. EHB will grant EHN the exclusive Canadian distribution rights to EHB’s award-winning product line in exchange for 49% equity ownership of EHN. EHB’s product line consists of nutritional supplements, which use non-cannabis, non-psychoactive plant-based bioactive compounds to support the body’s endocannabinoid system.”

Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) trumpets itself as a licensed producer of medical marijuana under the Access to Cannabis for Medical Purposes Regulations, which allows the company to produce and sell medical marijuana and cannabis oils to clients and other licensed producers.

Individuals may become clients of the company by registering with the company through its secure online portal or via telephone after the individual has received a medical document signed by a licensed health care practitioner setting out the daily quantity of dried marijuana, in grams, that the practitioner authorized for the person.

According to company materials, “Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) operates through Emerald Health Botanicals Inc., a wholly owned subsidiary and Licensed Producer under the Access to Cannabis for Medical Purposes Regulations. Botanicals is authorized to produce and sell both dried medical cannabis flower and medical cannabis oil in Canada. Botanicals currently operates an indoor facility in Victoria, BC, and is progressing on expansion plans for a 32-acre property in Metro Vancouver and a partnership with Village Farms, called Pure Sunfarms, utilizing a 25-acre existing greenhouse complex in Delta, BC. Botanicals is one of Canada’s most medically focused licensed producers, with a team highly experienced in life sciences product development and large-scale agribusiness. Its vision is to be a leading provider of cannabis products through its production capabilities, proprietary genetics, value-added products and branding, and superb customer experience. Emerald Health Therapeutics is associated with the Emerald Health group, which comprises multiple companies advancing diverse botanical, nutraceutical and pharmaceutical products that may provide wellness and medical benefits by interacting with the body’s endocannabinoid system.”

Find out when $EMHTF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

As noted above, EMHTF just announced that it has received conditional approval of the TSX Venture Exchange regarding its 51:49 joint venture with San Diego-based Emerald Health Bioceuticals, to be called Emerald Health Naturals.

The chart shows 3% piled on for shareholders of the name during the trailing month. Furthermore, the listing has registered increased average transaction volume recently, with the past month seeing 46% above the average volume levels in play in this stock over the longer term.

According to the company’s release, “market research commissioned by the Company identified that approximately 60% of legal cannabis users also use natural health products. This strong consumer overlap between the two markets creates a unique opportunity for the Company to establish its health brand through EHN and begin sales of endocannabinoid-supporting products in natural health product channels. These channels are not authorized to sell cannabis under the Canadian federal cannabis regulations for recreational use which came into force on October 17, 2018. However, if these channels are approved in the future, the Company expects to be well positioned to introduce its cannabis-based products into these channels.”

Now commanding a market cap of $364.99M, EMHTF has a significant war chest ($72.7M) of cash on the books, which is balanced by about $26.3M in total current liabilities. One should also note that debt has been growing over recent quarters. EMHTF is pulling in trailing 12-month revenues of $1.1M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 15.7%. This is an exciting story, and we look forward to a follow-up chapter as events transpire. Sign-up for continuing coverage on shares of $EMHTF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $EMHTF, either long or short, and we have not been compensated for this article.

Latest article

Precigen Inc. (NASDAQ:PGEN) Stock is Soaring, Here is Why

Precigen Inc. (PGEN) shares are trading at higher $7.49 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

McDonald’s Corporation (MCD)’s Stock is Jumping, Here is Why

McDonald's Corporation (MCD) shares are trading at lower $218.33 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Can We Expect More Volatility From Ceridian HCM Holding Inc. (CDAY)?

Ceridian HCM Holding Inc. (CDAY) shares are trading at higher $99.39 and the avg recommendation for the stock is Moderate Buy, while the current...

When Will Staffing 360 Solutions Inc. (STAF) Slow Down

Staffing 360 Solutions Inc. (STAF) shares are trading at higher $1.17 and the avg recommendation for the stock is Moderate Buy. To add more...

ArcelorMittal (NYSE:MT) is Gaining Momentum on Earnings Catalyst

ArcelorMittal (MT) shares are trading at lower $18.28 and the avg recommendation for the stock is Strong Buy, while the current analyst price target...